HJ, L., J, P., DI, O., EL, H., N, S., S, S., & JS, P. (2022). Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver. JAMA network open, 5(5), e2212419. https://doi.org/10.1001/jamanetworkopen.2022.12419
Chicago Style (17th ed.) CitationHJ, Lanham, Papac J, Olmos DI, Heydemann EL, Simonetti N, Schmidt S, and Potter JS. "Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver." JAMA Network Open 5, no. 5 (2022): e2212419. https://doi.org/10.1001/jamanetworkopen.2022.12419.
MLA (9th ed.) CitationHJ, Lanham, et al. "Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver." JAMA Network Open, vol. 5, no. 5, 2022, p. e2212419, https://doi.org/10.1001/jamanetworkopen.2022.12419.